Soldano Ferrone

46.6k total citations
872 papers, 35.0k citations indexed

About

Soldano Ferrone is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Soldano Ferrone has authored 872 papers receiving a total of 35.0k indexed citations (citations by other indexed papers that have themselves been cited), including 638 papers in Immunology, 314 papers in Radiology, Nuclear Medicine and Imaging and 243 papers in Oncology. Recurrent topics in Soldano Ferrone's work include Immunotherapy and Immune Responses (427 papers), Monoclonal and Polyclonal Antibodies Research (307 papers) and T-cell and B-cell Immunology (262 papers). Soldano Ferrone is often cited by papers focused on Immunotherapy and Immune Responses (427 papers), Monoclonal and Polyclonal Antibodies Research (307 papers) and T-cell and B-cell Immunology (262 papers). Soldano Ferrone collaborates with scholars based in United States, Italy and Germany. Soldano Ferrone's co-authors include Barbara Seliger, Robert L. Ferris, Michele Pellegrino, Francesco M. Marincola, M. A. Pellegrino, Michael Campoli, Theresa L. Whiteside, R. Reisfeld, Chien‐Chung Chang and Francesco Indiveri and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Soldano Ferrone

860 papers receiving 33.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Soldano Ferrone 21.8k 14.0k 10.6k 6.0k 2.8k 872 35.0k
Ronald Levy 20.4k 0.9× 14.4k 1.0× 11.4k 1.1× 11.8k 2.0× 1.3k 0.5× 694 44.9k
Ian Clark‐Lewis 14.7k 0.7× 12.0k 0.9× 9.9k 0.9× 2.1k 0.4× 1.8k 0.7× 202 29.6k
Yang‐Xin Fu 22.5k 1.0× 14.2k 1.0× 9.8k 0.9× 2.0k 0.3× 3.0k 1.1× 377 37.9k
Michael B. Brenner 27.8k 1.3× 5.7k 0.4× 9.9k 0.9× 2.9k 0.5× 1.5k 0.6× 295 40.8k
Douglas T. Fearon 15.2k 0.7× 6.6k 0.5× 5.4k 0.5× 2.7k 0.5× 1.5k 0.6× 178 24.5k
Catherine Sautès‐Fridman 15.3k 0.7× 14.6k 1.0× 7.8k 0.7× 2.8k 0.5× 3.7k 1.3× 251 27.8k
Meenhard Herlyn 8.6k 0.4× 17.1k 1.2× 26.4k 2.5× 4.5k 0.8× 6.1k 2.2× 545 42.8k
Stuart F. Schlossman 22.1k 1.0× 6.4k 0.5× 8.2k 0.8× 10.3k 1.7× 1.1k 0.4× 338 35.6k
Jeffrey Schlom 19.9k 0.9× 19.1k 1.4× 12.6k 1.2× 9.9k 1.6× 1.8k 0.7× 783 38.9k
Giorgio Parmiani 14.3k 0.7× 10.6k 0.8× 10.1k 1.0× 1.4k 0.2× 3.1k 1.1× 422 23.3k

Countries citing papers authored by Soldano Ferrone

Since Specialization
Citations

This map shows the geographic impact of Soldano Ferrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soldano Ferrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soldano Ferrone more than expected).

Fields of papers citing papers by Soldano Ferrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soldano Ferrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soldano Ferrone. The network helps show where Soldano Ferrone may publish in the future.

Co-authorship network of co-authors of Soldano Ferrone

This figure shows the co-authorship network connecting the top 25 collaborators of Soldano Ferrone. A scholar is included among the top collaborators of Soldano Ferrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soldano Ferrone. Soldano Ferrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaremba, Anne, Antje Sucker, Gennadiy Zelinskyy, et al.. (2023). HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance. Clinical Cancer Research. 29(15). 2894–2907. 9 indexed citations
2.
Datar, Ila, Sacha C. Hauc, Shruti Desai, et al.. (2021). Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non–Small Cell Lung Cancer. Clinical Cancer Research. 27(10). 2837–2847. 26 indexed citations
3.
Chauvin, Joë-Marc, Mignane Ka, Ornella Pagliano, et al.. (2020). IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma. Clinical Cancer Research. 26(20). 5520–5533. 114 indexed citations
4.
Trivedi, Sumita, Raghvendra M. Srivastava, Fernando Concha‐Benavente, et al.. (2016). Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients. Clinical Cancer Research. 22(21). 5229–5237. 103 indexed citations
5.
Srivastava, Raghvendra M., Sumita Trivedi, Fernando Concha‐Benavente, et al.. (2015). STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients. Cancer Immunology Research. 3(8). 936–945. 64 indexed citations
6.
Riccardo, Federica, Selina Iussich, Lorella Maniscalco, et al.. (2014). CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA. Clinical Cancer Research. 20(14). 3753–3762. 60 indexed citations
7.
Leibowitz, Michael S., Rahul Srivastava, Pedro A. Andrade Filho, et al.. (2013). SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells. Clinical Cancer Research. 19(4). 798–808. 63 indexed citations
8.
Geldres, Claudia, Barbara Savoldo, Valentina Hoyos, et al.. (2013). T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo. Clinical Cancer Research. 20(4). 962–971. 80 indexed citations
9.
Yeung, Jacky T., Ronald L. Hamilton, Koji Ohnishi, et al.. (2013). LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma. Clinical Cancer Research. 19(7). 1816–1826. 71 indexed citations
10.
Rivera, Zeyana, Soldano Ferrone, Xinhui Wang, et al.. (2012). CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma. Clinical Cancer Research. 18(19). 5352–5363. 76 indexed citations
11.
Zarour, Hassane M. & Soldano Ferrone. (2011). Cancer immunotherapy: Progress and challenges in the clinical setting. European Journal of Immunology. 41(6). 1510–1515. 24 indexed citations
12.
Wang, Xinhui, Akihiro Katayama, Yangyang Wang, et al.. (2011). Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4. Cancer Research. 71(24). 7410–7422. 51 indexed citations
13.
Bukur, Juergen, Soldano Ferrone, Graham Pawelec, et al.. (2011). Association of IFN-γ Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines. Clinical Cancer Research. 17(9). 2668–2678. 49 indexed citations
14.
Burns, William R., Yangbing Zhao, Timothy L. Frankel, et al.. (2010). A High Molecular Weight Melanoma-Associated Antigen–Specific Chimeric Antigen Receptor Redirects Lymphocytes to Target Human Melanomas. Cancer Research. 70(8). 3027–3033. 63 indexed citations
15.
Tomaso, Tiziano Di, Stefania Mazzoleni, Ena Wang, et al.. (2010). Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients. Clinical Cancer Research. 16(3). 800–813. 278 indexed citations
16.
Yang, Jianbo, Matt A. Price, Menashe Bar‐Eli, et al.. (2009). Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition. Cancer Research. 69(19). 7538–7547. 79 indexed citations
17.
Goto, Yasufumi, Takaaki Arigami, Minoru Kitago, et al.. (2008). Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Molecular Cancer Therapeutics. 7(11). 3642–3653. 93 indexed citations
18.
Maciag, Paulo, Matthew M. Seavey, Zhen-Kun Pan, Soldano Ferrone, & Yvonne Paterson. (2008). Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature. Cancer Research. 68(19). 8066–8075. 74 indexed citations
19.
Tsuda, Naotake, David Z. Chang, Takashi Mine, et al.. (2007). Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells. Cancer Research. 67(17). 8378–8387. 29 indexed citations
20.
Anichini, Andrea, Roberta Mortarini, Daisuke Nonaka, et al.. (2006). Association of Antigen-Processing Machinery and HLA Antigen Phenotype of Melanoma Cells with Survival in American Joint Committee on Cancer Stage III and IV Melanoma Patients. Cancer Research. 66(12). 6405–6411. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026